COLUMBIA UNIVERSITY HEALTH SCIENCES
Modulating the localization and persistence of microbial neoantigen vaccine vectors to enhance therapeutic efficacy
Modulating the localization and persistence of microbial neoantigen vaccine vectors to enhance therapeutic efficacy is a funding opportunity from COLUMBIA UNIVERSITY HEALTH SCIENCES, up to 638827, closing May 31, 2030.
May 31, 2030
(1400d left)Overview
PROJECT SUMMARY The development of neoantigen cancer vaccines is transforming cancer immunotherapy – providing an approach to stimulate pre-existing and de novo anti-tumor T cell responses. These vaccines are designed to introduce tumor-specific neoantigens to activate the immune system, and can be amplified through…